Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
N/A
35,479 Added 3444.56%
36,509 $106,000
Q1 2024

May 15, 2024

SELL
N/A
-578 Reduced 35.95%
1,030 $3,000
Q4 2023

Feb 13, 2024

BUY
$1.08 - $2.92 $1,736 - $4,695
1,608 New
1,608 $4,000
Q2 2023

Aug 14, 2023

SELL
$0.32 - $0.52 $106 - $173
-334 Reduced 2.59%
12,572 $5,000
Q1 2023

May 09, 2023

BUY
$0.34 - $1.05 $1,978 - $6,111
5,820 Added 82.13%
12,906 $6,000
Q4 2022

Feb 10, 2023

SELL
$0.76 - $1.44 $500 - $947
-658 Reduced 8.5%
7,086 $5,000
Q3 2022

Nov 10, 2022

SELL
$0.25 - $1.08 $1,198 - $5,177
-4,794 Reduced 38.24%
7,744 $6,000
Q2 2022

Aug 15, 2022

BUY
N/A
9,932 Added 381.12%
12,538 $9,000
Q1 2022

May 12, 2022

SELL
N/A
-269 Reduced 9.36%
2,606 $3,000
Q4 2021

Feb 14, 2022

BUY
N/A
603 Added 26.54%
2,875 $3,000
Q3 2021

Nov 15, 2021

BUY
N/A
2,272 New
2,272 $3,000

Others Institutions Holding JUPW

About Jupiter Wellness, Inc.


  • Ticker JUPW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 22,095,000
  • Market Cap $64.5M
  • Description
  • Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and J...
More about JUPW
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.